Covered recipient · General Payments record
DRAGAN DJORDJEVIC
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$7,320.28
- Reported across 371 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $477.74 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $191.67 | 9 |
| Novo Nordisk AS | $97.84 | 5 |
| Acerta Pharma LLC | $39.17 | 2 |
| Janssen Pharmaceuticals, Inc | $34.54 | 1 |
| EISAI INC. | $30.92 | 2 |
| Seqirus USA Inc | $21.61 | 1 |
| ABBVIE INC. | $18.35 | 1 |
| Merck Sharp & Dohme Corporation | $15.08 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.53 | 1 |
| Lilly USA, LLC | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.35 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103646746 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.32 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105847545 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.85 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105512123 | CMS |
| Eisai Inc. | $13.85 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110742625 | CMS |
| Eisai Inc. | $17.07 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110742623 | CMS |
| Janssen Pharmaceuticals, Inc | $34.54 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078003868 | CMS |
| Lilly USA, LLC | $14.03 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136174078 | CMS |
| Merck Sharp & Dohme LLC | $15.08 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141842767 | CMS |
| Novo Nordisk Inc | $16.95 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096671445 | CMS |
| Novo Nordisk Inc | $22.66 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097092498 | CMS |
| Novo Nordisk Inc | $17.26 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096676741 | CMS |
| Novo Nordisk Inc | $18.86 | 08/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097810384 | CMS |
| Novo Nordisk Inc | $22.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096859016 | CMS |
| PFIZER INC. | $26.33 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131020632 | CMS |
| PFIZER INC. | $23.24 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131390670 | CMS |
| PFIZER INC. | $25.38 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131466879 | CMS |
| PFIZER INC. | $9.09 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131919793 | CMS |
| PFIZER INC. | $27.13 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131613738 | CMS |
| PFIZER INC. | $6.16 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131940235 | CMS |
| PFIZER INC. | $21.67 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131972675 | CMS |
| PFIZER INC. | $27.07 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132103145 | CMS |
| PFIZER INC. | $25.60 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131201603 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.53 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153514840 | CMS |
| Seqirus USA Inc | $21.61 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125631338 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.